Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prime Medicine, Inc. | 375,000 | reported | 23 Feb 2026 | tx 11+1,634,812−361,990 |
| Juno Therapeutics, Inc. | 75,788 | reported | 05 Mar 2018 | tx 8+263,692−263,692 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | GRANT_AWARD | Prime Medicine, Inc. | 375,000 | 0.00 USD | deriv |
| 01 Aug 2025 | OTHER | Prime Medicine, Inc. | 180,995 | — | deriv |
| 01 Aug 2025 | GRANT_AWARD | Prime Medicine, Inc. | 180,995 | — | deriv |
| 01 Aug 2025 | OTHER | Prime Medicine, Inc. | 180,995 | — | deriv |
| 01 Aug 2025 | GRANT_AWARD | Prime Medicine, Inc. | 180,995 | — | deriv |
| 21 May 2025 | PURCHASE | Prime Medicine, Inc. | 100,000 | 1.13 USD | |
| 08 May 2025 | GRANT_AWARD | Prime Medicine, Inc. | 80,416 | 0.00 USD | deriv |
| 27 Feb 2025 | GRANT_AWARD | Prime Medicine, Inc. | 275,000 | 0.00 USD | deriv |
| 17 May 2024 | GRANT_AWARD | Prime Medicine, Inc. | 80,416 | 0.00 USD | deriv |
| 21 Feb 2024 | GRANT_AWARD | Prime Medicine, Inc. | 180,995 | 0.00 USD | deriv |
| 31 Mar 2023 | GRANT_AWARD | Prime Medicine, Inc. | 180,995 | 0.00 USD | deriv |
| 05 Mar 2018 | OTHER | Juno Therapeutics, Inc. | 40,788 | — | |
| 05 Mar 2018 | OTHER | Juno Therapeutics, Inc. | 35,000 | — | |
| 05 Mar 2018 | OTHER | Juno Therapeutics, Inc. | 35,004 | — | |
| 05 Mar 2018 | OTHER | Juno Therapeutics, Inc. | 152,900 | — | deriv |
| 31 Jan 2018 | GRANT_AWARD | Juno Therapeutics, Inc. | 40,788 | 0.00 USD | |
| 25 Nov 2017 | GRANT_AWARD | Juno Therapeutics, Inc. | 35,004 | 0.00 USD | |
| 25 Nov 2017 | GRANT_AWARD | Juno Therapeutics, Inc. | 35,000 | 0.00 USD | |
| 25 Nov 2017 | GRANT_AWARD | Juno Therapeutics, Inc. | 152,900 | 0.00 USD | deriv |